Hypercholesterolemia News and Research

RSS
Hypercholesterolemia is a condition characterized by very high levels of cholesterol in the blood. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals (particularly egg yolks, meat, poultry, fish, and dairy products). The body needs this substance to build cell membranes, make certain hormones, and produce compounds that aid in fat digestion. Too much cholesterol, however, increases a person's risk of developing heart disease.

People with hypercholesterolemia have a high risk of developing a form of heart disease called coronary artery disease. This condition occurs when excess cholesterol in the bloodstream is deposited in the walls of blood vessels, particularly in the arteries that supply blood to the heart (coronary arteries). The abnormal buildup of cholesterol forms clumps (plaque) that narrow and harden artery walls. As the clumps get bigger, they can clog the arteries and restrict the flow of blood to the heart. The buildup of plaque in coronary arteries causes a form of chest pain called angina and greatly increases a person's risk of having a heart attack.

Inherited forms of hypercholesterolemia can also cause health problems related to the buildup of excess cholesterol in other tissues. If cholesterol accumulates in tendons, it causes characteristic growths called tendon xanthomas. These growths most often affect the Achilles tendons and tendons in the hands and fingers. Yellowish cholesterol deposits under the skin of the eyelids are known as xanthelasmata. Cholesterol can also accumulate at the edges of the clear, front surface of the eye (the cornea), leading to a gray-colored ring called an arcus cornealis.
Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Regulus Therapeutics wins exclusive rights to modulate microRNAs

Regulus Therapeutics wins exclusive rights to modulate microRNAs

USPTO issues Notice of Allowance for U.S. patent application in the 'Crooke' patent family

USPTO issues Notice of Allowance for U.S. patent application in the 'Crooke' patent family

Myrrh resin may have cholesterol-lowering properties

Myrrh resin may have cholesterol-lowering properties

Regulus Therapeutics to host educational webinar about microRNA biology

Regulus Therapeutics to host educational webinar about microRNA biology

Fruit flies use same molecular mechanisms as humans for maintaining cholestrol

Fruit flies use same molecular mechanisms as humans for maintaining cholestrol

Study on the genetics of osteoarthritis

Study on the genetics of osteoarthritis

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Presence of increased body fat hinders the loss of body weight

Presence of increased body fat hinders the loss of body weight

Xeomin receives approval for post-stroke spasticity of upper limb in European countries

Xeomin receives approval for post-stroke spasticity of upper limb in European countries

New pre-clinical data from Alnylam Pharmaceuticals' ALN-VSP program presented

New pre-clinical data from Alnylam Pharmaceuticals' ALN-VSP program presented

Findings of Merck's anacetrapib phase IIb study presented at the AHA sessions

Findings of Merck's anacetrapib phase IIb study presented at the AHA sessions

Pediatric data for Pfizer's Lipitor submitted to the EMEA

Pediatric data for Pfizer's Lipitor submitted to the EMEA

Genzyme and Isis Pharmaceuticals announce phase 3 study data of mipomersen

Genzyme and Isis Pharmaceuticals announce phase 3 study data of mipomersen

Additional data from Aegerion Pharmaceuticals' ongoing lomitapide Phase III trial

Additional data from Aegerion Pharmaceuticals' ongoing lomitapide Phase III trial

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Alnylam Pharmaceuticals and Roche team up to develop specific RNAi therapeutic products

Alnylam Pharmaceuticals and Roche team up to develop specific RNAi therapeutic products

New molecular pathway for preventing potassium from being excreted normally through kidney identified

New molecular pathway for preventing potassium from being excreted normally through kidney identified

Breastfeeding: ADA position paper details health benefits for both infants and mothers

Breastfeeding: ADA position paper details health benefits for both infants and mothers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.